NDLI: Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Please wait, while we are loading the content...

Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.

The study of novel DNA vaccines against tuberculosis: Induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis

Novel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy

Applications and challenges of multivalent recombinant vaccines.

Murine infection models for vaccine development: the malaria example.

Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.

Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.

Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus.

Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197

Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.

Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation.

Are vaccination models suitable to determine whether probiotics have beneficial health effects in the general population?

Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26.

Progress in the elimination of measles and congenital rubella in Central Italy.

Influenza epidemiology in Italy two years after the 2009–2010 pandemic: Need to improve vaccination coverage

Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines.

Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.

Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy.

Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Immunotherapy in new pre-clinical models of HPV-associated oral cancers

A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge

Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants.

Neisseria lactamica antigens complexed with a novel cationic adjuvant.

Results of the rubella elimination program in Catalonia (Spain), 2002-2011.

Surveillance of influenza viruses in the post-pandemic era (2010-2012) in Northern Italy.

Surveillance of hospitalized and outpatient cases of pertussis in Catalonia from 2003 to 2009.

Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes.

Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.

Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector.

Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study.

A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.

Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.

Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.

Influenza sentinel surveillance network: a public health-primary care collaborative action to assess influenza A(H1N1)pmd09 in Catalonia, Spain.

Eighth World Congress on Vaccines, Immunisation and Immunotherapy.

Letter from the editor.

Year: 2013 Volume: 9 Issue: 2

Year: 2013 Volume: 9 Issue: 1

Year: 2012 Volume: 8

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Ciruela, Pilar Soldevila, Núria Selva, Laura Hernández, Sergi Garcia-Garcia, Juan Jose Moraga, Fernando de Sevilla, Mariona F. Codina, Gemma Planes, Ana Maria Esteva, Cristina Coll, Francis Cardeñosa, Neus Jordan, Iolanda Batalla, Joan Salleras, Luis Muñoz-Almagro, Carmen Domínguez, Angela
Spatial Coverage	Spain
Description	Country affiliation: Spain Author Affiliation: Ciruela P ( Public Health Agency of Catalonia)
Abstract	The aim of this study was to investigate risk factors for the most common serotypes of invasive pneumococcal disease (IPD). A total of 293 IPD cases were analyzed in children aged 3-59 mo in a community with intermediate vaccination coverage with the 7-valent pneumococcal vaccine (PCV7). IPD cases were reviewed during 2007-2009 in two pediatric hospitals in Catalonia (Spain). A multivariate analysis using unconditional logistic regression was performed to estimate the adjusted odds ratio. PCV7 coverage was 45.4%. Pneumonia with empyema (64.5%) was the most frequent clinical manifestation. The most common serotypes were: serotype 1 (21.2%), 19A (16.0%), 3 (12.6%) and 7F/A (6.8%). 70.0% of serotypes found were included in the 13-valent conjugate vaccine (PCV13), 39.2% in the 10-valent conjugate vaccine and 8.1% in the PCV7. PCV7 was protective in IPD cases due to PCV7-serotypes (aOR: 0.15, 95% CI:0.04-0.55). Serotype 1 was positively associated with attending day care or school (aOR: 3.55, 95% CI: 1.21-10.38) and age 24-59 mo (aOR: 7.70, 95% CI:2.70-21.98). Serotype 19A was positively associated with respiratory infection in the previous month (aOR: 2.26, 95% CI: 1.03-4.94), non-penicillin susceptible IPD (aOR: 1.89, 95% CI:1.13-3.16) and negatively associated with age 24-59 mo (aOR: 0.19, 95% CI:0.09-0.41). Serotype 3 was positively associated with vaccination (aOR: 4.87, 95% CI:2.05-11.59). No factors were associated with serotype 7F/A. Vaccination with pneumococcal vaccines including more serotypes may reduce the risk of disease in our setting.
File Format	HTM / HTML
ISSN	21645515
e-ISSN	2164554X
Journal	Human Vaccines & Immunotherapeutics
Issue Number	3
Volume Number	9
Language	English
Publisher	Taylor & Francis
Publisher Date	2013-03-01
Publisher Place	United States
Access Restriction	Open
Subject Keyword	Discipline Immunology Discipline Therapeutics Pneumococcal Infections Epidemiology Microbiology Streptococcus Pneumoniae Classification Child, Preschool Infant Pneumococcal Vaccines Immunology Risk Assessment Risk Factors Serogroup Spain Isolation & Purification Research Support, Non-u.s. Gov't
Content Type	Text
Resource Type	Article
Subject	Immunology and Allergy Immunology Pharmacology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Serotypes and genotypes of invasive pneumococci in the central part of Slovenia.

Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.

Increase in invasive nonvaccine pneumococcal serotypes at two hospitals in Barcelona: was replacement disease to blame?

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain

Nasopharyngeal carriage of Streptococcus pneumoniae: prevalence and risk factors in HIV-positive children in Tanzania.

The host immune dynamics of pneumococcal colonization: implications for novel vaccine development.

A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era.

Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Similar Documents

Serotypes and genotypes of invasive pneumococci in the central part of Slovenia.

Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.

Increase in invasive nonvaccine pneumococcal serotypes at two hospitals in Barcelona: was replacement disease to blame?

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain

Nasopharyngeal carriage of Streptococcus pneumoniae: prevalence and risk factors in HIV-positive children in Tanzania.

The host immune dynamics of pneumococcal colonization: implications for novel vaccine development.

A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era.

Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades.

Are risk factors associated with invasive pneumococcal disease according to different serotypes?